Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in Alzheimer's disease.

P Cras

    Acta Clinica Belgica
    |January 5, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Alzheimer's disease, a common dementia, is projected to quadruple by 2050. Recent advancements offer new insights into its causes, diagnosis, and potential treatments, including novel therapies and vaccination strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Does ECT raise the risk of a recurrent stroke?]

    Tijdschrift voor psychiatrie·2023
    Same author

    HIV sero-positivity and risk factors for ischaemic and haemorrhagic stroke in hospitalised patients in Uganda: A prospective-case-control study.

    Public health in practice (Oxford, England)·2022
    Same author

    Stroke coach: a pilot study of a personal digital coaching program for patients after ischemic stroke.

    Acta neurologica Belgica·2019
    Same author

    Postural control and the relation with cervical sensorimotor control in patients with idiopathic adult-onset cervical dystonia.

    Experimental brain research·2018
    Same author

    Sensory processing and central pain modulation in patients with chronic shoulder pain: A case-control study.

    Scandinavian journal of medicine & science in sports·2017
    Same author

    The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.

    Molecular psychiatry·2015
    Same journal

    MEFV variants as phenotypic modifiers in ankylosing spondylitis: a genetic interaction analysis with HLA-B27.

    Acta clinica Belgica·2026
    Same journal

    What Europe should (not) learn from the new Dietary Guidelines for Americans.

    Acta clinica Belgica·2026
    Same journal

    Real-world evidence on In-hospital statin use and mortality in geriatric patients.

    Acta clinica Belgica·2026
    Same journal

    TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

    Acta clinica Belgica·2026
    Same journal

    A decade of insulin pump therapy in a Belgian paediatric diabetes centre: longitudinal outcomes and evolving practices.

    Acta clinica Belgica·2026
    Same journal

    Pneumococcal vaccination in Belgian adults: a practical translation of the 2025 Superior Health Council guidelines.

    Acta clinica Belgica·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Genetics
    • Pharmacology

    Background:

    • Alzheimer's disease (AD) is the leading cause of dementia, with prevalence expected to quadruple by 2050.
    • Recent decades have seen significant progress in understanding AD pathogenesis, diagnosis, and therapeutic interventions.
    • Key genetic factors, including mutations in amyloid precursor protein (APP), presenilin-1 (PS1), and presenilin-2 (PS2) genes, and apolipoprotein E (APOE) gene isotypes, influence AD phenotypes.

    Discussion:

    • The role of secretases in amyloid-beta (Aβ) generation within senile plaques is elucidated, highlighting potential therapeutic targets.
    • The interplay between vascular lesions and dementia, including the Lewy body variant of Alzheimer's disease, has been refined.
    • Acetylcholine deficiency in AD can be partially addressed by acetylcholinesterase inhibitors.

    Related Experiment Videos

    Key Insights:

    • Genetic mutations and apolipoprotein E isotypes significantly impact Alzheimer's disease phenotypes.
    • Understanding secretase pathways offers novel therapeutic avenues for amyloid plaque reduction.
    • Acetylcholinesterase inhibitors provide symptomatic relief by addressing acetylcholine deficiency.

    Outlook:

    • Amyloid vaccination in transgenic mouse models presents a promising new perspective for AD prevention and treatment.
    • Continued research into genetic and molecular mechanisms will drive the development of targeted therapies.
    • Integrated approaches considering vascular factors and neurotransmitter deficits may improve patient outcomes.